DiaMedica (DMAC) Initiates Pivotal Ischemic Stroke Study Posted byZacks Equity Research September 14, 2021 Leave a comment on DiaMedica (DMAC) Initiates Pivotal Ischemic Stroke Study DiaMedica (DMAC) is developing its recombinant KLK1 protein candidate, DM199 for treating patients who suffered an acute ischemic stroke in the last 2…